Effects of tibolone and raloxifene on bone mineral density in osteopenic postmenopausal women

By Delmas P.   Davis S.   Hensen J.   Adami S.   Os S.   Nijland E.  

Osteoporosis International, Vol. 19, Iss. 8, 2008-08 ,pp. : 1153-1160

Springer Publishing Company

Access to resources Recommend Favorite

Treatment with alendronate plus calcium, alendronate alone, or calcium alone for postmenopausal low bone mineral density

By Bonnick Sydney   Broy Susan   Kaiser Fran   Teutsch Carol   Rosenberg Elizabeth   DeLucca Paul   Melton Mary  

Current Medical Research and Opinion, Vol. 23, Iss. 6, 2007-06 ,pp. : 1341-1349

Informa Healthcare

Access to resources Recommend Favorite

Comparison of Bone and Total Alkaline Phosphatase and Bone Mineral Density in Postmenopausal Osteoporotic Women Treated with Alendronate

By Watts N. B.   Jenkins D. K.   Visor J. M.   Casal D. C.   Geusens P.  

Osteoporosis International, Vol. 12, Iss. 4, 2001-05 ,pp. : 279-288

Springer Publishing Company

Access to resources Recommend Favorite

Patient compliance with alendronate, risedronate and raloxifene for the treatment of osteoporosis in postmenopausal women

By Ringe J. D.   Christodoulakos G. E.   Mellström D.   Petto H.   Nickelsen T.   Marín F.   Pavo I.  

Current Medical Research and Opinion, Vol. 23, Iss. 11, 2007-11 ,pp. : 2677-2687

Informa Healthcare

Access to resources Recommend Favorite

Randomized trial comparing efficacies of zoledronate and alendronate for improving bone mineral density and inhibiting bone remodelling in women with post‐menopausal osteoporosis

By  

JOURNAL OF CLINICAL PHARMACY & THERAPEUTICS, Vol. 41, Iss. 5, 2016-10 ,pp. : 519-523

John Wiley & Sons Inc

Access to resources Recommend Favorite